Autopsy report · NCT03580005

A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.

“The study was cancelled prior to the enrollment of any participants.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Pfizer

Sponsor type

Industry

Conditions

Attention Deficit Hyperactivity Disorder (ADHD); Attention Deficit Hyperactivity Disorder

Interventions

methylphenidate HCl ERCT; Placebo

Participants

0

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.